We did not obtain evidence for associations between PRLs and other factors associated with greater susceptibility to MS, for example, baseline serum anti‐EBNA‐1 or calcitriol levels, or HLA DRB1*1501 genotype. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.